Viewing Study NCT00079768


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-03-01 @ 10:49 PM
Study NCT ID: NCT00079768
Status: COMPLETED
Last Update Posted: 2010-06-17
First Post: 2004-03-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Alemtuzumab to Treat Sporadic Inclusion Body Myositis
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module